MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-29-2023
Chembio Diagnostics ROE Ratio 2011-2025 | CEMI
Annual ROE Ratio Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -130.86 | -98.95 | -91.88 | -56.9 | -23.6 | -48.72 | -77.74 | -13.57 | -5.77 | 2.63 | 6.78 | 49.69 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 49.69 | -130.86 | -40.74 |
Quarterly ROE Ratio Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -105.67 | -118.96 | -94.59 | -119.71 | -92.63 | -112.57 | -119.22 | -87.45 | -66.18 | -81.92 | -77.72 | -62.74 | -40.72 | -47.66 | -38.86 | -30.79 | -14.09 | -29.37 | -26.89 | -38.32 | -48.72 | -48.33 | -56.32 | -88.32 | -77.74 | -66.51 | -56.54 | -11.68 | -13.57 | -11.27 | -10.17 | -7.15 | -3.25 | 0.3 | 5.22 | 4.77 | 3.93 | 1.82 | -3.84 | -0.42 | 3.24 | 7.05 | 12.96 | 12.3 | 4.23 | 3.81 | 1.56 | -1.14 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.96 | -119.71 | -38.54 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 16.69 | -1.62 % | $ 99.4 M |  Israel |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 11.98 | 0.76 % | $ 340 M | Israel |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
DexCom
DXCM
|
26.18 | $ 65.96 | -1.49 % | $ 25.5 B |  USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.5 | - | $ 18.8 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.66 | 5.75 % | $ 179 M |  China |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.58 | -2.78 % | $ 2.01 M | USA |
 |
IQVIA Holdings
IQV
|
22.63 | $ 221.84 | -0.19 % | $ 40.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
4.0 | $ 38.4 | -0.6 % | $ 1.07 B | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 225.96 | -0.16 % | $ 165 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 26.96 | -0.66 % | $ 815 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Myriad Genetics
MYGN
|
-18.16 | $ 6.94 | -3.74 % | $ 629 M | USA |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
-8.72 | $ 12.03 | 1.48 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 6.77 | -1.38 % | $ 1.47 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 19.75 | -3.96 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 102.36 | -2.75 % | $ 4.04 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
-43.74 | $ 2.1 | -1.18 % | $ 533 M | USA |
 |
Anixa Biosciences
ANIX
|
-62.78 | $ 3.5 | -2.23 % | $ 112 K | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 0.31 | -9.72 % | $ 9.1 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 26.48 | -0.54 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
-40.56 | $ 24.68 | -1.14 % | $ 32 M | USA |
 |
Quidel Corporation
QDEL
|
60.8 | $ 28.71 | -0.31 % | $ 1.21 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | $ 45.07 | -0.33 % | $ 10 B | Niderland |
 |
Guardant Health
GH
|
312.48 | $ 103.62 | 1.52 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
10.96 | $ 16.82 | -0.06 % | $ 4.76 B | USA |
 |
Soleno Therapeutics
SLNO
|
-71.74 | $ 50.98 | -1.97 % | $ 2.05 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 134.26 | -0.45 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 195.91 | 1.49 % | $ 10.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.78 | $ 568.7 | -0.52 % | $ 217 B | USA |
 |
Trinity Biotech plc
TRIB
|
287.88 | $ 0.96 | -10.07 % | $ 61.9 M |  Irlanda |
 |
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 30.85 | -0.26 % | $ 1.85 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 183.46 | 0.49 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 7.64 | -2.74 % | $ 991 M | USA |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 406.95 | 0.96 % | $ 29.9 B | Schweiz |